NCT05327023 2026-04-28Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1/2 Recruiting430 enrolled